Printed from https://fyi.org.nz/similar/request/32255-supply-agreement-with-pfizer-for-supply-of-cominarty-brand-of-covid-19-vaccine on May 27, 2026 18:59

Requests similar to 'Supply agreement with Pfizer for supply of Cominarty brand of Covid-19 vaccine'

Purchase of Pfizer Comirnaty JN.1 and Comirnaty Omicron XBB.1.5
Response by Ministry of Health to John Armstrong on .
Partially successful.
Kia ora John   Thank you for your request for official information, received 4 November 2025.   Please find attached response to your request...
Kostaive self-amplifying mRNA in New Zealand
Request sent to Pharmaceutical Management Agency by John Armstrong on .
Successful.
I seek information for Kostaive self-amplifying mRNA as listed on pg 10, section 8 - Market Analysis, in a prior response received from Pharmac, ref...
Regulatory Status and Use of “Kostaive” (Zapomeran) Vaccine in New Zealand
Response by Ministry of Health to John Armstrong on .
Successful.
Kia ora John       Please find attached a letter regarding your request for official information. If you wish to discuss any aspect of your re...
Please supply the Pfizer Comirnaty BNT162b2 contract with the NZ Government
Response by Pharmaceutical Management Agency to John Armstrong on .
Refused.
Kia ora John   Please find attached a response to your request for official information.   Ngā mihi,   Government Services | Pharmac ____...
Conflicts of Interest - Tony Blakely and John Whitehead
Request sent to Department of Internal Affairs by John Armstrong on .
Successful.
Can you please supply all documentation, minutes of meetings, e-mails, risk assessments for Tony Blakely (Commissioner) and John Whitehead (Commissi...
Conflicts of Interest Covid Inquiry phase 2
Request sent to Department of Internal Affairs by John Armstrong on .
Partially successful.
Can you please supply all documentation, minutes of meetings, e-mails, risk assessments for Grant Illingworth (Chair), Judy Kavanagh (Commissioner)...
Why have you restricted Ivermectin?
Response by Pharmaceutical Management Agency to Annie Weston on .
Successful.
Mōrena Annie Please find a response to your request about ivermectin attached with this email. Ngā mihi Melody Willis (she/her) | Government Servic...
Obligation to transfer OIA to correct holder of information for the Pfizer Contract
Response by Ministry of Health to John Armstrong on .
Partially successful.
Kia ora John,   Please find attached a response to your official information act request.    Ngā mihi     OIA Services Team Ministry of H...
Official Information Act Request – Provisions of Pfizer Vaccine Procurement Agreements
Response by Ministry of Business, Innovation & Employment to John Armstrong on .
Refused.
Kia ora John,   Thank you for your request for official information received on 8 April 2026 (as below)   We are contacting you to clarify par...
Supply Chain Risk Assessment
Response by Pharmaceutical Management Agency to levi on .
Awaiting classification.
Kia ora Levi   Please find attached a response to your request for official information.   Ngā mihi,   Government Services | Pharmac ____...
7 - ADHD Medicines, Funding, Access, and Equity
Response by Pharmaceutical Management Agency to Elspeth Baker-Vevers on .
Partially successful.
  Kia ora Elspeth,   Please find attached our response letter and the relevant documents released to you under the Official Information Act.  ...
Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit
Follow up sent to Pharmaceutical Management Agency by Micky Turner on .
Successful.
Hi Melody, Thanks for providing the information! Here is a summary of the details: Remdesivir is a failed Ebola drug. It was designed to treat E...
The total legal costs incurred by Pharmac in relation to proceedings: CIV-2024-404-845 – Whittome v Director-General of Health: common bundle
Response by Pharmaceutical Management Agency to John Armstrong on .
Successful.
Kia ora John   Please find attached a response to your request for official information.   Ngâ mihi,   Government Services | Pharmac ____...
Process and progress of approval for pediatric/under 5’s covid vaccines
Response by Pharmaceutical Management Agency to Scout Barbour-Evans on .
Partially successful.
Tēnā koe Scout Please find a response to your request for information attached with this email. Ngā mihi Melody Willis (she/her) | Government Servi...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Response by Pharmaceutical Management Agency to J Bruning on .
Successful.
Kia ora Please find a response to your request for information attached with this email. Ngā mihi Melody Willis (she/her) | Government Services Adv...
Reappointment / Appointments to the Board of Pharmac – Te Pātaka Whaioranga
Response by Ministry of Health to john luke on .
Successful.
    Kia ora John Luke       Please find attached a letter regarding your request for official information. If you wish to discuss any aspe...
Assessment bias toward new medicines - Ivermectin and Pfizer antiviral PF-07321332
Response by Ministry of Health to Adam Irish on .
Partially successful.
Kia ora Adam   Please find a response to your request attached with this email.   Ngā mihi     Melody Willis ([1]she/her) | Government Se...
All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors
Response by Pharmaceutical Management Agency to Stefan Clausing on .
Awaiting classification.
Kia ora Stefan, Please find a response to your request attached to this email. Kind regards, Gendi McFadyen| Government Services Advisor Te Pātaka W...
Funding for Ixekizumab
Response by Pharmaceutical Management Agency to Ms Faulkner on .
Successful.
Kia ora Ms Faulkner, Please find a response to your request attached to this email. Kind regards, Gendi McFadyen| Government Services Advisor Te Pāt...
Electrical Workers Registration Board (EWRB) and MBIE requirements for Digital ID
Request sent to Ministry of Business, Innovation & Employment by John Armstrong on .
Partially successful.
I am a registered Electrician, as part of my 2 yearly cycle I need to do my competency refresher and apply for registration valid for another 2 year...
Official Information Act Request – Legal Advice Regarding Disclosure of Vaccine Procurement Agreements
Response by Crown Law Office to John Armstrong on .
Awaiting classification.
Kia ora John   Please see attached for the response to your Official Information Act request of 11 March 2026.   Kind regards | Ngā mihi nui...
Discussions, correspondence, minutes etc in 2025 on Covid vaccine use in pregnant women
Response by Ministry of Health to Erika Whittome on .
Successful.
Kia ora Erika,   Please find attached a response to your request for official information.   Ngā mihi,   Government Services | Pharmac __...
Legal costs in relation to proceedings: CIV-2024-404-845 – Whittome v Director-General of Health
Response by Pharmaceutical Management Agency to John Armstrong on .
Refused.
Kia ora John,   Thank you for your email.   We have interpreted your question below as enquiring about the financial impact on Pharmac of disclosi...
Vanlafaxine - Bioavailability studies
Response by Pharmaceutical Management Agency to R Whyte on .
Awaiting classification.
Dear R Whyte   Please see attached the response to your OIA request.     Kind regards Dean Zeng PHARMAC   16 April 2018 Via Email: [e...
Management of Stelazine (trifluoperazine) supply
Response by Pharmaceutical Management Agency to WGRH on .
Information not held.
Dear Dr Harrison, PHARMAC is extending the response date for your request, please see letter attached. Please let me know if you have any questions o...